Testing prucalopride for thinking skills in schizophrenia
Treatments studied
Part of Mental health clinical trials.
This study tests whether a medicine called prucalopride can improve thinking and memory in people with schizophrenia. It is for adults who are stable on their current medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with schizophrenia by a doctor.
- You are between 18 and 55 years old.
- You have been on the same medication dose for at least 3 months and are feeling stable.
- You can read and write in English or Kannada.
- You are not currently pregnant or breastfeeding, and have no active suicidal thoughts.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new treatment that may help with thinking and memory problems in people with schizophrenia. It is for people whose schizophrenia symptoms are stable and who are already on a steady medication.
This trial studies whether adding cromoglicate to your usual antipsychotic medicine can improve schizophrenia symptoms. It’s designed for outpatients who are already on a stable treatment and still have certain ongoing symptom scores.
This study tests whether a brain stimulation approach can improve thinking (cognition) in people with schizophrenia and how it changes brain electrical signals and a brain chemical called GABA. It may help researchers understand new ways to support thinking and symptoms.
This trial tests if a supplement called PQQ can help with cognitive problems and negative symptoms (like lack of motivation) in people with schizophrenia. It may offer a new way to support current treatment.
This study tests a noninvasive brain stimulation treatment (tDCS) to improve thinking and memory problems in people with early schizophrenia. If you qualify, you would receive the study treatment while continuing stable schizophrenia care.
This trial is testing whether it is safe to slowly reduce or stop anticholinergic medications (benztropine or trihexyphenidyl) in people with schizophrenia. It aims to see if stopping these drugs can help with thinking and memory without causing worsening movement problems.
Hear when a new Schizophrenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.